Hypoxia Inducible Factor (HIF)-2? protein expression in solid tumors promotes stem-like phenotype in cancer stem cells and increases tumorigenic potential in non-stem cancer cells. Recently, we have shown HIF-1/2? gene expression is correlated to neuroblastoma (NB) poor survival and to undifferentiated tumor state; HIF-2? protein was demonstrated to enhance aggressive features of the disease. In this study, we used proteomic experiments on NB cells to investigate HIF-2? downstream-regulated proteins and/or pathways with the aim of providing novel therapeutic targets and/or bad prognosis markers. We verified that pathways mostly altered by HIF-2? perturbation are involved in tumor progression. In particular, HIF-2? induces alteration of central metabolism and splicing control pathways. Simultaneously, WNT, RAS/MAPK and PI3K/AKT activity and/or expression are affected and may impact on the sensitivity and the intensity of HIF-2?-regulated pathways. Furthermore, genes coding the identified HIF-2?-related markers built a signature able to stratify NB patients with unfavorable outcome. Taken together, our findings underline the relevance of dissecting the downstream effects of a poor survival marker in developing targeted therapy and improving patient stratification. Future prospective studies are needed to translate the use of these data into the clinical practice.
Proteomic alterations in response to Hypoxia Inducible Factor 2# in normoxic Neuroblastoma cells.
Sassi M;Scaloni A;
2016
Abstract
Hypoxia Inducible Factor (HIF)-2? protein expression in solid tumors promotes stem-like phenotype in cancer stem cells and increases tumorigenic potential in non-stem cancer cells. Recently, we have shown HIF-1/2? gene expression is correlated to neuroblastoma (NB) poor survival and to undifferentiated tumor state; HIF-2? protein was demonstrated to enhance aggressive features of the disease. In this study, we used proteomic experiments on NB cells to investigate HIF-2? downstream-regulated proteins and/or pathways with the aim of providing novel therapeutic targets and/or bad prognosis markers. We verified that pathways mostly altered by HIF-2? perturbation are involved in tumor progression. In particular, HIF-2? induces alteration of central metabolism and splicing control pathways. Simultaneously, WNT, RAS/MAPK and PI3K/AKT activity and/or expression are affected and may impact on the sensitivity and the intensity of HIF-2?-regulated pathways. Furthermore, genes coding the identified HIF-2?-related markers built a signature able to stratify NB patients with unfavorable outcome. Taken together, our findings underline the relevance of dissecting the downstream effects of a poor survival marker in developing targeted therapy and improving patient stratification. Future prospective studies are needed to translate the use of these data into the clinical practice.File | Dimensione | Formato | |
---|---|---|---|
prod_358331-doc_117206.pdf
accesso aperto
Descrizione: Proteomic alterations in response to Hypoxia Inducible Factor 2# in normoxic Neuroblastoma cells.
Tipologia:
Documento in Pre-print
Licenza:
Nessuna licenza dichiarata (non attribuibile a prodotti successivi al 2023)
Dimensione
2.12 MB
Formato
Adobe PDF
|
2.12 MB | Adobe PDF | Visualizza/Apri |
cimmino-et-al-2016-proteomic-alterations-in-response-to-hypoxia-inducible-factor-2α-in-normoxic-neuroblastoma-cells.pdf
solo utenti autorizzati
Descrizione: Proteomic alterations in response to Hypoxia Inducible Factor 2# in normoxic Neuroblastoma cells
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
4.86 MB
Formato
Adobe PDF
|
4.86 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.